315 related articles for article (PubMed ID: 19477370)
1. Different metabolic effects of selective and nonselective beta-blockers rather than mere heart rate reduction may be the mechanisms by which beta-blockade prevents cardiovascular events.
Fragasso G; Cera M; Margonato A
J Am Coll Cardiol; 2009 Jun; 53(22):2105; author reply 2106-7. PubMed ID: 19477370
[No Abstract] [Full Text] [Related]
2. Beta-blockers and hypertension.
Cruickshank JM
J Am Coll Cardiol; 2009 Jun; 53(22):2105-6; author reply 2106-7. PubMed ID: 19477369
[No Abstract] [Full Text] [Related]
3. Beta-blocker-induced heart rate reduction: too simplistic to explain the deleterious effects of beta-blockers.
Laurent S; Boutouyrie P
J Am Coll Cardiol; 2009 Jun; 53(22):2103-4; author reply 2106-7. PubMed ID: 19477367
[No Abstract] [Full Text] [Related]
4. Beta-blocker-induced heart rate lowering, cardioprotection, and hypertension.
Khan SS
J Am Coll Cardiol; 2009 Jun; 53(22):2104-5; author reply 2106-7. PubMed ID: 19477368
[No Abstract] [Full Text] [Related]
5. Beta-blockers as first-line antihypertensive therapy the crumbling continues.
Lavie CJ; Messerli FH; Milani RV
J Am Coll Cardiol; 2009 Sep; 54(13):1162-4. PubMed ID: 19761937
[No Abstract] [Full Text] [Related]
6. Current role of beta-blockers in the treatment of hypertension.
Aronow WS
Expert Opin Pharmacother; 2010 Nov; 11(16):2599-607. PubMed ID: 20426702
[TBL] [Abstract][Full Text] [Related]
7. Atenolol is dead: long live beta-blockade.
Cockcroft JR
J Am Coll Cardiol; 2009 Jun; 53(22):2102; author reply 2106-7. PubMed ID: 19477365
[No Abstract] [Full Text] [Related]
8. Beta-blockers do not impair the cardiovascular benefits of endurance training in hypertensives.
Westhoff TH; Franke N; Schmidt S; Vallbracht-Israng K; Zidek W; Dimeo F; van der Giet M
J Hum Hypertens; 2007 Jun; 21(6):486-93. PubMed ID: 17330056
[TBL] [Abstract][Full Text] [Related]
9. [The metabolic effects of beta-receptor blockers. What is of practical importance in antihypertensive therapy?].
Sawicki PT; Berger M
Dtsch Med Wochenschr; 1992 May; 117(22):875-9. PubMed ID: 1350758
[No Abstract] [Full Text] [Related]
10. Beta blockers in hypertension and cardiovascular disease.
Ong HT
BMJ; 2007 May; 334(7600):946-9. PubMed ID: 17478848
[TBL] [Abstract][Full Text] [Related]
11. beta-Blockers and hypertension: a therapeutic reappraisal.
Panjrath GS; Sawhney S; Messerli FH
Postgrad Med; 2005 Dec; 118(6 Suppl Beta-Blockers):26-33. PubMed ID: 19667708
[TBL] [Abstract][Full Text] [Related]
12. [Heart rate: a cardiovascular risk factor that can no longer be ignored].
Palatini P
G Ital Cardiol (Rome); 2006 Feb; 7(2):119-28. PubMed ID: 16532723
[TBL] [Abstract][Full Text] [Related]
13. Metabolic effects of beta-blockers: importance of dissociating newer from conventional agents.
Sarafidis PA; Bakris GL
J Hypertens; 2007 Jan; 25(1):249-52; author reply 252-3. PubMed ID: 17143201
[No Abstract] [Full Text] [Related]
14. Are beta blockers effective first-line treatments for hypertension?
Cayley WE
Am Fam Physician; 2007 Nov; 76(9):1306-8. PubMed ID: 18019872
[No Abstract] [Full Text] [Related]
15. Is there a heart rate paradox--demystification of the myths?
Kjekshus J
J Intern Med; 2009 Sep; 266(3):242-7. PubMed ID: 19702792
[No Abstract] [Full Text] [Related]
16. [Beta blockers for hypertension. No negative influence on insulin resistance].
MMW Fortschr Med; 2002 Feb; 144(8):50. PubMed ID: 11910826
[No Abstract] [Full Text] [Related]
17. Antihypertensive therapy with adrenergic beta-receptor blockers and vasodilators.
Aenishänslin W; Pestalozzi-Kerpel J; Dubach UC; Imhof PR; Turri M
Eur J Clin Pharmacol; 1972 Jun; 4(3):177-81. PubMed ID: 4144064
[No Abstract] [Full Text] [Related]
18. Evolving mechanisms of action of beta blockers: focus on nebivolol.
Mason RP; Giles TD; Sowers JR
J Cardiovasc Pharmacol; 2009 Aug; 54(2):123-8. PubMed ID: 19528811
[TBL] [Abstract][Full Text] [Related]
19. [Principal pharmacological properties of different beta-blockers, possibilities and new perspectives of their uses].
Antelava N; Antelava A; Pachkoria K; Pirtskhalaishvili N
Georgian Med News; 2006 Dec; (141):38-46. PubMed ID: 17261885
[TBL] [Abstract][Full Text] [Related]
20. Beta-receptor blockade, physical activity, and metabolism.
Lohmann FW; Loesment WA; Kaehler H
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S45-52. PubMed ID: 11527136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
